. Author manuscript; available in PMC: 2020 Sep 11.

Published in final edited form as: Ann Oncol. 2020 May 28;31(9):1240–1250. doi: 10.1016/j.annonc.2020.05.019

Table 2.

Hazard ratios and 95% CIs for quintiles of the gene expression signature score in validation data

Quintile	N	Deaths	Median survival^a	HR (95% CI)	Adjusted for age and stage	Adjusted for molecular subtype age and stage
					HR (95% CI)	HR (95% CI)
Q1	214	81	9.47 (8.32 to –)	0.44 (0.33–0.58)	0.34 (0.22–0.55)	0.37 (0.23–0.59)
Q2	213	117	5.38 (4.63–6.97)	0.73 (0.57–0.93)	0.71 (0.55–0.91)	0.74 (0.58–0.96)
Q3	213	145	3.80 (3.34–4.60)
Q4	213	158	3.23 (2.85–3.68)	1.56 (1.25–1.96)	1.56 (1.24–1.97)	1.56 (1.24–1.96)
Q5	214	179	2.27 (2.09–2.62)	2.23 (1.78–2.78)	2.11 (1.67–2.67)	2.07 (1.63–2.61)

CI, confidence interval; HR, hazard ratio.

Median survival (95% CI) in years for patients in the validation set.